These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 18201410)

  • 1. Successful pregnancy outcome with the levonorgestrel-releasing intrauterine system.
    Pilkington A; Misfar N; Polson DW
    J Fam Plann Reprod Health Care; 2008 Jan; 34(1):60. PubMed ID: 18201410
    [No Abstract]   [Full Text] [Related]  

  • 2. Levonorgestrel-releasing intrauterine system or medroxyprogesterone for heavy menstrual bleeding: a randomized controlled trial.
    Chelmow D
    Obstet Gynecol; 2010 Dec; 116(6):1455-1456. PubMed ID: 21099621
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis.
    Gallos ID; Shehmar M; Thangaratinam S; Papapostolou TK; Coomarasamy A; Gupta JK
    Am J Obstet Gynecol; 2010 Dec; 203(6):547.e1-10. PubMed ID: 20934679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of levonorgestrel intrauterine system for medical indications in adolescents.
    Bayer LL; Hillard PJ
    J Adolesc Health; 2013 Apr; 52(4 Suppl):S54-8. PubMed ID: 23535058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1.
    Pakarinen P; Lähteenmäki P; Rutanen EM
    Acta Obstet Gynecol Scand; 1999 May; 78(5):423-8. PubMed ID: 10326889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena.
    Gemzell-Danielsson K; Schellschmidt I; Apter D
    Fertil Steril; 2012 Mar; 97(3):616-22.e1-3. PubMed ID: 22222193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of menorrhagia with the levonorgestrel releasing intrauterine system: effects on ovarian function and uterus.
    Tasci Y; Caglar GS; Kayikcioglu F; Cengiz H; Yagci B; Gunes M
    Arch Gynecol Obstet; 2009 Jul; 280(1):39-42. PubMed ID: 19066923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful pregnancy following insertion of a levonorgestrel-releasing intrauterine system in two infertile patients with complex atypical endometrial hyperplasia.
    Qi X; Zhao W; Duan Y; Li Y
    Gynecol Obstet Invest; 2008; 65(4):266-8. PubMed ID: 18196936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of levonorgestrel-releasing intrauterine system use on menstrual blood loss and the hemostatic, fibrinolytic/inhibitor systems in women with menorrhagia.
    Koh SC; Singh K
    J Thromb Haemost; 2007 Jan; 5(1):133-8. PubMed ID: 17010149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fertility and endocrine effects of intra-abdominally misplaced intrauterine system for more than 2 years: a case report and review of the literature.
    Botros G; Haddad N
    Hum Fertil (Camb); 2009 Jun; 12(2):119-21. PubMed ID: 19802962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of oligoamenorrhea at 1-year follow-up in premenopausal women using a levonorgestrel-releasing intrauterine system.
    de Jonge ET; Yigit R; Molenberghs G; Straetmans D; Ombelet W
    Contraception; 2007 Aug; 76(2):91-5. PubMed ID: 17656176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.
    Morin-Papunen L; Martikainen H; McCarthy MI; Franks S; Sovio U; Hartikainen AL; Ruokonen A; Leinonen M; Laitinen J; Järvelin MR; Pouta A
    Am J Obstet Gynecol; 2008 Nov; 199(5):529.e1-529.e10. PubMed ID: 18533124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulated progesterone receptor A and B coinciding with successful treatment of endometrial hyperplasia by the levonorgestrel impregnated intrauterine system.
    Orbo A; Arnes M; Pettersen I; Larsen K; Hanssen K; Moe B
    Acta Obstet Gynecol Scand; 2010 Nov; 89(11):1438-46. PubMed ID: 20955098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two cases of abortion and premature birth after removal of a levonorgestrel-releasing intrauterine system.
    Rollnik JD; Lück HJ; Giersig C
    Eur J Contracept Reprod Health Care; 2002 Dec; 7(4):244-6. PubMed ID: 12648298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In women over 35 years of age who smoke, does mirena (levonorgestrel-releasing intrauterine system) reduce the risk of DVTs compared to oral contraceptives?
    Marshall M; Jordan K; Brand JL; Welborn TL
    J Okla State Med Assoc; 2013 Sep; 106(9):362-3. PubMed ID: 24354055
    [No Abstract]   [Full Text] [Related]  

  • 16. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
    Sheng J; Zhang WY; Zhang JP; Lu D
    Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levonorgestrel-releasing intrauterine system compared to low dose combined oral contraceptive pills for idiopathic menorrhagia: a randomized clinical trial.
    Shaaban MM; Zakherah MS; El-Nashar SA; Sayed GH
    Contraception; 2011 Jan; 83(1):48-54. PubMed ID: 21134503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the Levonorgestrel-IUS in the treatment of menorrhagia: assessment of quality of life in Turkish users.
    Gorgen H; Api M; Akça A; Cetin A
    Arch Gynecol Obstet; 2009 Jun; 279(6):835-40. PubMed ID: 19018547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of levonorgestrel given after or before ovulation.
    Ventura-Juncá P; Besio M; Santos M
    Contraception; 2008 Jun; 77(6):463-4; author reply 464-5. PubMed ID: 18477498
    [No Abstract]   [Full Text] [Related]  

  • 20. Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system.
    Eisenberg DL; Schreiber CA; Turok DK; Teal SB; Westhoff CL; Creinin MD;
    Contraception; 2015 Jul; 92(1):10-6. PubMed ID: 25934164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.